Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

MKM Partners Maintains Neutral on Cracker Barrel Old, Lowers Price Target to $110

MKM Partners analyst Brett Levy maintains Cracker Barrel Old (NASDAQ:CBRL) with a Neutral and lowers the price target from $115 to $110.

byBenzinga Newsdesk

June 8, 2022

1 minute read

MKM Partners analyst Brett Levy maintains Cracker Barrel Old (NASDAQ:CBRL) with a Neutral and lowers the price target from $115 to $110.

Citigroup Upgrades AZEK Co to Buy, Lowers Price Target to $30

By Benzinga Newsdesk

Today, 11:18 AM

Citigroup analyst Anthony Pettinari upgrades AZEK Co (NYSE:AZEK) from Neutral to Buy and lowers the price target from $36 to $30.

AZEK

Getaround In Talks To Merge With Altitude Acquisition

By Michael Horton

Today, 11:18 AM

-Reuters

ALTU

Analyst Ratings

HC Wainwright & Co. Maintains Buy Rating for Vera Therapeutics: Here’s What You Need To Know

By Benzinga Insights

Today, 11:18 AM

HC Wainwright & Co. has decided to maintain its Buy rating of Vera Therapeutics (NASDAQ:VERA) and raise its price target from $35.00 to $36.00. Shares of Vera Therapeutics are trading down 1.88% over the last 24 hours, at $18.25 per share.

VERA

Analyst Ratings

Where Avantor Stands With Analysts

By Benzinga Insights

Today, 11:18 AM

Within the last quarter, Avantor (NYSE:AVTR) has observed the following analyst ratings:

AVTR

MKM Partners Maintains Neutral on Cracker Barrel Old, Lowers Price Target to $110

Related Posts

Citigroup Upgrades AZEK Co to Buy, Lowers Price Target to $30

Getaround In Talks To Merge With Altitude Acquisition

HC Wainwright & Co. Maintains Buy Rating for Vera Therapeutics: Here’s What You Need To Know

Where Avantor Stands With Analysts